Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.

10.1016/j.metabol.2021.154911

Saved in:

Bibliographic Details
Main Authors:	Tan, Eunice Xiang-Xuan, Lee, Jonathan Wei-Jie, Jumat, Nur Halisah, Chan, Wah-Kheong, Treeprasertsuk, Sombat, Goh, George Boon-Bee, Fan, Jian-Gao, Song, Myeong Jun, Charatcharoenwitthaya, Phunchai, Duseja, Ajay, Imajo, Kento, Nakajima, Atsushi, Seki, Yosuke, Kasama, Kazunori, Kakizaki, Satoru, Lesmana, Laurentius A, Zheng, Kenneth I, Zheng, Ming-Hua, Koh, Calvin J, Ho, Khek-Yu, Goh, Khean-Lee, Wong, Vincent Wai-Sun, Dan, Yock-Young
Other Authors:	ASIA RESEARCH INSTITUTE
Format:	Article
Published:	Elsevier BV 2021
Subjects:	Asian Fatty liver Fibrosis NAFLD Obesity
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/206183
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study
by: Eunice Xiang Xuan Tan, et al.
Published: (2022)

Insights into the role of PPARβ/δ in NAFLD
by: Tan, Nguan Soon, et al.
Published: (2018)

Lessons on drug development: a literature review of challenges faced in nonalcoholic fatty liver disease (NAFLD) clinical trials
by: Chen, Joel Yeh Siang, et al.
Published: (2023)

CD4+ T cells mediate the development of liver fibrosis in high fat diet-induced NAFLD in humanized mice
by: Her, Zhisheng, et al.
Published: (2020)

NAFLD HUMAN IN-VITRO MODEL FOR NOVEL THERAPEUTIC TARGETS INVESTIGATION
by: LAM DO THUY UYEN HA
Published: (2024)

A MACHINE LEARNING-BASED APPROCH FOR QUANTITATIVE AND AUTOMATED NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)/NON-ALCOHOLIC STEATOHEPATITIS (NASH) ASSESSMENT USING PATHOLOGICAL STAINED SLIDES
by: XU YUMENG
Published: (2019)

An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
by: Leow, W.-Q., et al.
Published: (2021)

Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: The GOASIA study
by: Pitisuttithum, P., et al.
Published: (2021)

CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice
by: Her, Z., et al.
Published: (2021)

The Effect of Diabetes and Prediabetes on the Prevalence, Complications and Mortality in Non-alcoholic Fatty Liver Disease.
by: Ng, Cheng Han, et al.
Published: (2022)

MOLECULAR DISSECTION OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: NOOSHIN NOURBAKHSH
Published: (2023)

Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years
by: Ludwig, Ulla, et al.
Published: (2015)

Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis
by: Wah Kheong Chan, et al.
Published: (2020)

Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
by: Panyavee Pitisuttithum, et al.
Published: (2020)

Roles of the microRNAs in fatty liver lipid accumulation
by: GENG WEI
Published: (2012)

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
by: Jain, Mukul R., et al.
Published: (2019)

The NAFLD fibrosis score : a prognostic predictor for mortality and liver complications among NAFLD patients
by: Sombat Treeprasertsuk
Published: (2013)

Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression
by: Bruinstroop, E, et al.
Published: (2022)

How should we manage patients with non-alcoholic fatty liver disease in 2007?
by: Chan, H.L.-Y., et al.
Published: (2016)

DNA METHYLATION DYNAMICS AND EPIGENETIC MEMORY IN HIGHLY METABOLIC MAMMALIAN ORGANS
by: JAIME OLIVER PITFIELD WORSLEY
Published: (2018)

CYSTEINE THERAPEUTICS DEVELOPMENT FOR THE TREATMENT OF INFLAMMATORY DISEASES
by: NG MEI YING
Published: (2022)

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study
by: Tan E.X.X.
Published: (2023)

A MACHINE LEARNING BASED DIAGNOSTIC STUDY OF CHRONIC LIVER DISEASE USING STAINING TECHNIQUES
by: YU YANG
Published: (2020)

In-vitro validation of potential modulators of non-alcoholic fatty liver disease (NAFLD)
by: Tang, Daryl Woon Tat
Published: (2024)

Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives
by: Ng, Cheng Han, et al.
Published: (2022)

Lifestyle intervention enabled by mobile technology on weight loss in patients with nonalcoholic fatty liver disease: Randomized controlled trial
by: Lim, S.L., et al.
Published: (2021)

kadar leptin pada populasi non diabetes dengan dan tanpa non alcoholic fatty liver disease (NAFLD)
by: , SOFIA, Noor Asyiqah, et al.
Published: (2010)

Impact of Metabolic Risk Factors on the Severity and Outcome of Patients with Alcohol Associated Acute-on-Chronic Liver Failure.
by: Duseja, Ajay, et al.
Published: (2021)

Impact of Pparβ/δ deletion in non-parenchymal cells - liver physiology and disease (NAFLD)
by: Chen, Kelvin Jiapeng
Published: (2018)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
by: Kumar, Rahul, et al.
Published: (2023)

The lipid droplet as a potential therapeutic target in NAFLD
by: Goh, V.J., et al.
Published: (2016)

Non-alcoholic Fatty Liver Disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes
by: Abhasnee Sobhonslidsuk, et al.
Published: (2018)

Genome wide in-vivo functional genetic screen to identify novel modulators of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Lian, Ying
Published: (2022)

Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand
by: Pochamana Phisalprapa, et al.
Published: (2022)

The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Wasit Wongtrakul, et al.
Published: (2022)

Oxidative stress in NAFLD : role of nutrients and food contaminants
by: Rives, Clémence, et al.
Published: (2021)

Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD
by: Sinha, R.A, et al.
Published: (2020)

PENGARUH PEMBERIAN METFORMIN DAN VALSARTAN TERHADAP KADAR ADIPONEKTIN PADA PENDERITA SINDROMA METABOLIK DENGAN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
by: , Wawan Triharjanto, et al.
Published: (2014)

PENGARUH PEMBERIAN METFORMIN DAN TELMISARTAN TERHADAP KADAR ASAM LEMAK BEBAS PENDERITA SINDROM METABOLIK DENGAN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
by: , dr. Nur Rahmi Ananda, et al.
Published: (2014)

Gut-liver axis in nonalcoholic fatty liver disease (NAFLD)
by: Koo, Yolanda Wei Ling
Published: (2023)